Your email has been successfully added to our mailing list.

×
0 0 0 0.000627352572145612 0.000627352572145612 0 0 -0.0136225129951604
Stock impact report

Vaxcyte: Stunning PCV Data Readout Suggests Vaccine Maker Is A Strong Buy [Seeking Alpha]

Vaxcyte, Inc. (PCVX) 
Company Research Source: Seeking Alpha
Follow Summary Vaxcyte's stock surged this week due to promising Phase 1/2 data for its VAX-31 vaccine, showing superior immune responses compared to Pfizer's Prevnar 20. VAX-31 targets 31 strains, covering over 95% of IPD in U.S. adults, with Phase 3 trials expected to deliver top line data by mid-2026. Despite competition from Merck and GSK, Vaxcyte's innovative XpressCF platform offers a significant competitive edge in the growing PCV market. Investors should consider potential risks and wait for market stabilization post-fundraising, but the long-term upside remains compelling with possible +75% upside in play, in my view. There are some risks to consider - length of time to potential approval the most prominent - but it's rare to see such a compelling data set when market incumbents are so established. MicroStockHub/iStock via Getty Images Investment Overview - Background To Recent Explosive Share Price Growth Foster City, California based Vaxcyte ( NASDAQ: PCV Show less Read more
Impact Snapshot
Event Time:
PCVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for PCVX alerts
Opt-in for
PCVX alerts

from News Quantified
Opt-in for
PCVX alerts

from News Quantified